p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane-Reference-Cited by-同舟云学术

p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane

Published:2024-01-05 Issue:4 Volume:130 Page:613-619
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Vanacker Hélène^ORCID,Treilleux Isabelle,Schiffler Camille,Bieche Ivan,Campone Mario,Patsouris Anne^ORCID,Arnedos Monica,Cottu Paul H.^ORCID,Jacquin Jean-Philippe,Dalenc Florence,Pinton Antoine,Servant Nicolas,Attignon Valéry,Rouleau Etienne,Morel Alain,Legrand François,Jimenez Marta^ORCID,Andre Fabrice^ORCID,Bachelot Thomas^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41416-023-02549-8.pdf

Reference30 articles.

1. Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, et al. 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4). Ann Oncol août. 2018;29:1634–57.

2. Dodwell D, Wardley A, Johnston S. Postmenopausal advanced breast cancer: Options for therapy after tamoxifen and aromatase inhibitors. Breast. 2006;15:584–94.

3. Hortobagyi GN, Chen D, Piccart M, Rugo HS, Burris HA, Pritchard KI, et al. Correlative analysis of genetic alterations and everolimus benefit in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: results from BOLERO-2. JCO. 2016;34:419–26.

4. Miller TW, Hennessy BT, González-Angulo AM, Fox EM, Mills GB, Chen H, et al. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer. J Clin Invest. 2010;120:2406–13.

5. Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 2005;65:2554–9.